Search Results for '3tc-Switch'

3tc-Switch published presentations and documents on DocSlides.

EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
by felicity
ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...
Switching to TDF-FTC  from ABC-3TC for Hyperlipidemia
Switching to TDF-FTC from ABC-3TC for Hyperlipidemia
by trinity
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
DTG/3TC 1st line (GEMINI)
DTG/3TC 1st line (GEMINI)
by oryan
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in
LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in
by lucy
Virologically. Suppressed. OLE Trial. LPV-RTV + ....
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
Cases from the Clinic(ians):  Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
ClinicalTrials.gov
ClinicalTrials.gov
by lauren
Identifier: . NCT02770508 . Dual therapy based on ...
Novel Antiretroviral Studies and Strategies
Novel Antiretroviral Studies and Strategies
by danya
Bob Harrington, MD. University of Washington . Pre...
HIV 2020:  Time for change
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...
HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO
HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO
by hazel
Dr Laura Oyiengo. NATIONAL AIDS STI CONTROL PROGRA...
ADDP Training Programme Community Retail Pharmacy Drug Distribution Points
ADDP Training Programme Community Retail Pharmacy Drug Distribution Points
by jocelyn
(CRPDDP). Training Contents. Module 1. : . HIV Ove...
What’s new in the 2019 WHO Guidelines:
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Treatment Approaches to Achieve the 2
Treatment Approaches to Achieve the 2
by gabriella
nd. 90: Child Friendly Formulations . Victor Mu...
Meg  Doherty MD MPH PhD 23 July 2018
Meg Doherty MD MPH PhD 23 July 2018
by jordyn
WHO HQ. The role of DTG based regimens in first- a...
Monday, 23 July, 10:15-12:15
Monday, 23 July, 10:15-12:15
by della
Hall 11B, RAI Amsterdam. Uptake and Procurement of...
Interactive ART Cases From the Clinic: Is There One Right Answer?
Interactive ART Cases From the Clinic: Is There One Right Answer?
by megan
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
WHO ARV Forecasting Meeting
WHO ARV Forecasting Meeting
by sistertive
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
Comparison of INSTI  vs  EFV
Comparison of INSTI vs EFV
by mediumgeneral
STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...
Antiretroviral Therapy (ART)
Antiretroviral Therapy (ART)
by alexa-scheidler
Dr. S . Ntshalintshali. Ngwelezana. hospital. N...
Eric S.  Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-
Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-
by min-jolicoeur
implementation of Dolutegravir. Meireles MV. , Pa...
Missing formulations for paediatric HIV treatment and the Dakar Call for
Missing formulations for paediatric HIV treatment and the Dakar Call for
by trish-goza
Action. Improving Access to Optimized Treatment ....
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
1 Fundación Huésped, Buenos Aires, Argentina;
1 Fundación Huésped, Buenos Aires, Argentina;
by aaron
2. Instituto Nacional de Ciencias Médicas y Nutr...
Fixed-Dose Combination of
Fixed-Dose Combination of
by myesha-ticknor
Doravirine. /Lamivudine/TDF is Non-Inferior to . ...
Eric S.  Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Treatment of Children and Adolescents
Treatment of Children and Adolescents
by liane-varnes
Implementation Challenges. Annette H. Sohn, MD. T...
Treatment-Experienced Patients in Resource-Limited Settings
Treatment-Experienced Patients in Resource-Limited Settings
by pasty-toler
Susan M. Graham . Assistant Professor, Medicine a...
ART Initiation in Resource-Limited Settings
ART Initiation in Resource-Limited Settings
by lois-ondreau
Susan M. Graham . Assistant Professor, Medicine a...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...
Rationalizing Pediatric ARV Formularies:
Rationalizing Pediatric ARV Formularies:
by marina-yarberry
The IATT Optimal Pediatric ARV List. . Presented...
Young person with multi-class resistance: follow-up and man
Young person with multi-class resistance: follow-up and man
by luanne-stotts
(with perspectives from well-resourced and resour...
Updates on Individual and Universal HIV Treatment Strategies
Updates on Individual and Universal HIV Treatment Strategies
by norah
EECA INTERACT, November 19, 2019. Stefan Baral, MD...
Optimization of Antiretroviral Therapy
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
DTG vs LPV/r (DAWNING): Efficacy
DTG vs LPV/r (DAWNING): Efficacy
by winnie
by Baseline NRTI Resistance . and Second-Line NRTI...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
Introduction Characteristics, Treatment Patterns,
Introduction Characteristics, Treatment Patterns,
by cappi
and . Virologic. Outcomes . for Treatment-experie...